CoChat
Sign Up
Cited by 6

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Size transformable organic nanotheranostic agents for NIR-II imaging-guided oncotherapy

Su, Peng, Sun, Wenjun, Wang, Guoqin, Xu, Hongpan, Bao, Biqing, Wang, Lianhui·2024·Journal of Colloid and Interface Science
DOI 10.1016/j.jcis.2023.10.038
Open this paper in CoChat — free account

Abstract

Nanotheranostic agents combined the second near-infrared (NIR-II, 1000-1700 nm) fluorescence imaging with phototherapy strategy have attracted tremendous interest. However, the actual efficacy of NIR-II probes could be weakened by their limited accumulation and penetration in tumor tissues. Herein, a size-transformable NIR-II nanotheranostic agent (BBT-HASS@FPMPL NPs) is employed for simultaneously enhanced penetration and retention in deep tumor tissue to realize precise image and effective PTT therapy. BBT-HASS@FPMPL NPs were first formed by using hyaluronic acid (HA) chains and disulfide bonds as stimuli-responsive "lock" to efficiently load conjugated oligomer (BBTN + ), and then folic acid (FA) modified polylysine (FPMPL) shell was stacked at the surface by electrostatic interaction. Dual targeting with HA and FA is expected to lead to more selective targeting and better accumulation of BBT-HASS@FPMPL NPs in tumor sites. Simultaneously, obvious particle size reduction and charge reversal can be triggered in acidic tumor microenvironment to achieve deep intratumor filtration through transcytosis. Following tumor penetration, size change was further initiated by overexpressed hyaluronidase and GSH in tumor. Free BBTN + can be subsequently released from nanoparticles to promote specific intratumor retention, which synergistically enhance photothermal therapeutic efficacy. Owing to sufficient tumor accumulation and deep penetration, the NIR-II emission of BBTN + could furthe…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jcis.2023.10.038

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 40

  1. Kang, 2022, Tumor-Associated Immune-Cell-Mediated Tumor-Targeting Mechanism with NIR-II Fluorescence Imaging, Adv. Mater., 34, 2106500, 10.1002/adma.202106500 · DOI
  2. Liu, 2022, Versatile Types of Inorganic/Organic NIR-IIa/IIb Fluorophores: From Strategic Design toward Molecular Imaging and Theranostics, Chem. Rev., 122, 209, 10.1021/acs.chemrev.1c00553 · DOI
  3. Yu, 2019, NIR-II fluorescence in vivo confocal microscopy with aggregation-induced emission dots, Sci. Bull., 64, 410, 10.1016/j.scib.2019.02.019 · DOI
  4. Dang, 2022, Galactose conjugated boron dipyrromethene and hydrogen bonding promoted J-aggregates for efficiently targeted NIR-II fluorescence assistant photothermal therapy, J. Colloid Interf. Sci., 612, 287, 10.1016/j.jcis.2021.12.177 · DOI
  5. Cheng, 2022, Macromolecular conjugated cyanine fluorophore nanoparticles for tumor-responsive photo nanotheranostics, J. Colloid Interf. Sci., 626, 453, 10.1016/j.jcis.2022.06.134 · DOI
  6. Gao, 2021, Black SnO2-x based nanotheranostic for imaging-guided photodynamic/photothermal synergistic therapy in the second near-infrared window, Acta Biomater., 129, 220, 10.1016/j.actbio.2021.05.041 · DOI
  7. Meng, 2023, Near-infrared-II-activatable sulfur-deficient plasmonic Bi2S3-x-Au heterostructures for photoacoustic imaging-guided ultrasound enhanced high performance phototherapy, J. Colloid Interf. Sci., 644, 437, 10.1016/j.jcis.2023.04.108 · DOI
  8. Alifu, 2018, Single-Molecular Near-Infrared-II Theranostic Systems: Ultrastable Aggregation-Induced Emission Nanoparticles for Long-Term Tracing and Efficient Photothermal Therapy, ACS Nano, 12, 11282, 10.1021/acsnano.8b05937 · DOI
  9. Chen, 2019, Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery, Adv. Sci., 6, 1802070, 10.1002/advs.201802070 · DOI
  10. Sun, 2022, Ultrasound-Responsive Peptide Nanogels to Balance Conflicting Requirements for Deep Tumor Penetration and Prolonged Blood Circulation, ACS Nano, 16, 9183, 10.1021/acsnano.2c01407 · DOI
  11. Wang, 2022, Enhanced Intracellular Transcytosis of Nanoparticles by Degrading Extracellular Matrix for Deep Tissue Radiotherapy of Pancreatic Adenocarcinoma, Nano Lett., 22, 6877, 10.1021/acs.nanolett.2c01005 · DOI
  12. Zhang, 2020, Small Morph Nanoparticles for Deep Tumor Penetration via Caveolae-Mediated Transcytosis, ACS Appl. Mater. Interfaces, 12, 38499, 10.1021/acsami.0c06872 · DOI
  13. Zhou, 2019, Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy, Nat. Nanotechnol., 14, 799, 10.1038/s41565-019-0485-z · DOI
  14. Yan, 2022, Platelet Pharmacytes for the Hierarchical Amplification of Antitumor Immunity in Response to Self-Generated Immune Signals, Adv. Mater., 34, 2109517, 10.1002/adma.202109517 · DOI
  15. Liu, 2019, Tumor Microenvironment-Responsive Nanoshuttles with Sodium Citrate Modification for Hierarchical Targeting and Improved Tumor Theranostics, ACS Appl. Mater. Interfaces, 11, 25730, 10.1021/acsami.9b07957 · DOI
  16. Dai, 2020, Programmable prodrug micelle with size-shrinkage and charge-reversal for chemotherapy-improved IDO immunotherapy, Biomaterials, 241, 10.1016/j.biomaterials.2020.119901 · DOI
  17. Zhao, 2021, Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction, J. Control. Release, 335, 320, 10.1016/j.jconrel.2021.05.036 · DOI
  18. Chang, 2019, Targeting the Cell Membrane by Charge-Reversal Amphiphilic Pillar[5]arene for the Selective Killing of Cancer Cells, ACS Appl. Mater. Interfaces, 11, 38497, 10.1021/acsami.9b13492 · DOI
  19. Li, 2021, Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy, J. Control. Release, 338, 719, 10.1016/j.jconrel.2021.09.005 · DOI
  20. Li, 2021, Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapy, Bioact. Mater., 6, 3473
  21. Guo, 2020, Lapatinib-loaded acidity-triggered charge switchable polycarbonate-doxorubicin conjugate micelles for synergistic breast cancer chemotherapy, Acta Biomater., 118, 182, 10.1016/j.actbio.2020.09.051 · DOI
  22. Xu, 2020, A Size-Changeable Collagenase-Modified Nanoscavenger for Increasing Penetration and Retention of Nanomedicine in Deep Tumor Tissue, Adv. Mater., 32, 1906745, 10.1002/adma.201906745 · DOI
  23. Li, 2022, Bright Near-Infrared π-Conjugated Oligomer Nanoparticles for Deep-Brain Three-Photon Microscopy Excited at the 1700 nm Window in Vivo, ACS Nano, 16, 12480, 10.1021/acsnano.2c03813 · DOI
  24. Li, 2022, Organic NIR-II dyes with ultralong circulation persistence for image-guided delivery and therapy, J. Control. Release, 342, 157, 10.1016/j.jconrel.2022.01.005 · DOI
  25. Chen, 2017, Sequentially Responsive Shell-Stacked Nanoparticles for Deep Penetration into Solid Tumors, Adv. Mater., 29, 1701170, 10.1002/adma.201701170 · DOI
  26. Qian, 2020, Tumor-Cell-Surface Adherable Peptide-Drug Conjugate Prodrug Nanoparticles Inhibit Tumor Metastasis and Augment Treatment Efficacy, Nano Lett., 20, 4153, 10.1021/acs.nanolett.0c00152 · DOI
  27. Gao, 2018, Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells, Stem Cell Res Ther, 9, 243, 10.1186/s13287-018-0987-x · DOI
  28. Lu, 2018, Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles, Small, 14, 1702858, 10.1002/smll.201702858 · DOI
  29. Chen, 2020, Membrane-Anchoring Photosensitizer with Aggregation-Induced Emission Characteristics for Combating Multidrug-Resistant Bacteria, Angew. Chem. Int. Ed., 59, 632, 10.1002/anie.201907343 · DOI
  30. Wang, 2017, A Membrane-Intercalating Conjugated Oligoelectrolyte with High-Efficiency Photodynamic Antimicrobial Activity, Angew. Chem. Int. Ed., 56, 5031, 10.1002/anie.201701146 · DOI
  31. Song, 2017, Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy, J. Mater. Chem. B, 5, 6835, 10.1039/C7TB01548H · DOI
  32. Taghipour, 2022, An update on dual targeting strategy for cancer treatment, J. Control. Release, 349, 67, 10.1016/j.jconrel.2022.06.044 · DOI
  33. Liu, 2019, Dual-Functionalized Janus Mesoporous Silica Nanoparticles with Active Targeting and Charge Reversal for Synergistic Tumor-Targeting Therapy, ACS Appl. Mater. Interfaces, 11, 44582, 10.1021/acsami.9b15434 · DOI
  34. Miao, 2018, Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery, Colloid. Surface. b., 169, 313, 10.1016/j.colsurfb.2018.05.026 · DOI
  35. Hsu, 2020, pH-responsive polymeric micelles self-assembled from benzoic-imine-containing alkyl-modified PEGylated chitosan for delivery of amphiphilic drugs, Int. J. Biol. Macromol., 163, 1106, 10.1016/j.ijbiomac.2020.07.110 · DOI
  36. Zhang, 2023, Copper-Nitrogen-Coordinated Carbon Dots: Transformable Phototheranostics from Precise PTT/PDT to Post-Treatment Imaging-Guided PDT for Residual Tumor Cells, ACS Appl. Mater. Interfaces, 15, 3253, 10.1021/acsami.2c17525 · DOI
  37. Tang, 2023, Glutathione depletion-mediated in situ transformation of Prussian blue nanocubes for enhanced tumor-specific imaging and photoimmunotherapy, Inorg. Chem. Front., 10, 4054, 10.1039/D3QI00441D · DOI
  38. Xu, 2019, pH/NIR-responsive semiconducting polymer nanoparticles for highly effective photoacoustic image guided chemo-photothermal synergistic therapy, J. Control. Release, 293, 94, 10.1016/j.jconrel.2018.11.016 · DOI
  39. Gao, 2022, Single-walled carbon nanohorns-based smart nanotheranostic: From phototherapy to enzyme-activated fluorescence imaging-guided photodynamic therapy, J. Colloid Interf. Sci., 628, 273, 10.1016/j.jcis.2022.07.168 · DOI
  40. Zhou, 2022, Conjugated Oligoelectrolytes for Long-Term Tumor Tracking with Incremental NIR-II Emission, Adv. Mater., 34, 2201989, 10.1002/adma.202201989 · DOI

Cited by

Sorted by citations

See all 6

Metadata

Authors
Su, P., Sun, W., Wang, G., Xu, H., Bao, B., & Wang, L.
Venue
Journal of Colloid and Interface Science
Publisher
Elsevier BV
Published
2024-01
Volume
654
Pages
740-752
ISSN
0021-9797
DOI
10.1016/j.jcis.2023.10.038
Cited by
6
References
2
Language
en
Licence
Funders
National Natural Science Foundation of China (62235008, 62288102)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review